BioSTAR bioabsorbable septal repair implant
Michael J Mullen1, Carol A Devellian, Christian Jux
1Royal Brompton Hospital, Sydney Street, London SW3 6NP, England. m.mullen@rbh.nthames.nhs.uk
Expert Review of Medical Devices
|November 27, 2007
Summary
BioSTAR offers a novel bioabsorbable device for closing intra-atrial septal defects, unlike permanent implants. This technology aims to remodel into native tissue, promoting natural healing for structural heart disease.
Area of Science:
- Cardiovascular Medicine
- Biomaterials Science
- Medical Device Technology
Background:
- Percutaneous closure of intra-atrial septal defects is common for hemodynamic correction and stroke prevention.
- Current closure devices result in permanent cardiac implants, posing long-term considerations for young patients.
- There is a need for closure technologies that promote natural tissue healing and remodeling.
Purpose of the Study:
- To review atrial morphology and indications for septal defect closure.
- To discuss the development of BioSTAR, a novel bioabsorbable closure device.
- To present the design, testing, and clinical experience with BioSTAR.
Main Methods:
- Review of atrial morphology, focusing on patent foramen ovale.
- Exploration of current and emerging indications for septal defect closure.
- Detailed examination of the BioSTAR device, including its bioabsorbable material and design principles.
Main Results:
- BioSTAR is the first device using bioabsorbable material for structural heart disease treatment.
- The device is designed to remodel into native tissue post-closure.
- Clinical experience with BioSTAR demonstrates its potential for natural defect repair.
Conclusions:
- BioSTAR represents a significant advancement in treating structural heart disease.
- The bioabsorbable nature of BioSTAR offers a more natural healing process compared to permanent implants.
- This technology holds promise for improved long-term outcomes in patients requiring septal defect closure.
